First it was a campaign promise. Then a key plank of the Liberal-NDP supply and confidence agreement. Then it morphed into drug pricing reforms, which were delayed, and changed and delayed and ... well, we're still waiting. Meanwhile, the organization that helped devise the plan has seen resignations, amid accusations that the federal Liberal government has caved to huge pharmaceutical companies.

The promise of pharmacare goes back decades in Canadian politics. For a while it seemed like it might be within reach, or at least we'd get price relief on expensive drugs for those without insurance. Instead, we're still in limbo. What happened?

GUEST: Dr. Danyaal Raza, family physician; Assistant Professor, University of Toronto Department of Family & Community Medicine

We love feedback at The Big Story, as well as suggestions for future episodes. You can find us:

Through email at [email protected] 

Or @thebigstory.bsky.social on Bluesky